Becker's Hospital Review - Cardiology
SEPTEMBER 9, 2024
A cardiologist from the Heart and Vascular Institute at Longview (Texas) Regional Medical Center became the first in the nation to place a dual-chamber leadless pacemaker.
HCPLive
SEPTEMBER 9, 2024
New study finds ASCVD risk score often misses at-risk patients for first acute coronary syndrome, highlighting need for better prediction methods.
Science Daily - Heart Disease
SEPTEMBER 9, 2024
RNA is expelled from cells via cell death or active release, and can then find its way into blood plasma. Medical researchers have now developed machine learning models that use these cell-free molecular RNA dregs to diagnose pediatric inflammatory conditions that are difficult to differentiate. The diagnostic tool can accurately determine if a patient has Kawasaki disease (KD), Multisystem Inflammatory Syndrome in Children (MIS-C), a viral infection or a bacterial infection, while simultaneousl
HCPLive
SEPTEMBER 9, 2024
There was no difference in the incidence of BKPyV, CMV, or EBV in patients who received HCV NAT-positive donor kidneys versus those who received HCV NAT-negative donor kidneys.
American Heart News - Stroke News
SEPTEMBER 9, 2024
DALLAS, September 9, 2024 — While stroke is the fifth-leading overall cause of death in the United States, it disproportionately impacts Hispanic people. It is the third leading cause of death among Hispanic women and the fourth leading cause of death.
HCPLive
SEPTEMBER 9, 2024
Nearly 19% of dementia cases were attributable to ≥1 vision impairment in a nationally representative sample of older US adults.
Dr. Smith's ECG Blog
SEPTEMBER 9, 2024
Written by Willy Frick A 40 year old woman was at home cooking when she developed chest pain. She took an oxycodone and called EMS. Her presenting ECG is shown below: ECG 1 What do you think? I sent this to Drs. Meyers and Smith and the response was: "I’m quite confident that this is OMI." Here is the Queen's verdict with explainability: She sees OMI with low confidence.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
American Heart News - Stroke News
SEPTEMBER 9, 2024
DALLAS, 9 de septiembre de 2024 — Si bien el derrame cerebral es la quinta causa principal de muerte en los Estados Unidos, afecta desproporcionadamente a los hispanos. Es la tercera principal causa de muerte entre las mujeres hispanas y la cuarta.
HCPLive
SEPTEMBER 9, 2024
This feature highlights the views of 3 experts on the integration of patient-reported outcomes into the management of psoriatic disease.
American College of Cardiology
SEPTEMBER 9, 2024
"CV Sports Chat" is an interview series including expert discussions relative to sports and exercise cardiology and the health care management of athletes.
HCPLive
SEPTEMBER 9, 2024
HCPLive spoke to a healthcare expert who gave his thoughts on the Reagan Udall Foundation for the FDA’s recent meeting to discuss advancing treatments for PTSD.
Journal of Cardiothoracic Surgery
SEPTEMBER 9, 2024
Hypoxic pulmonary vasoconstriction is the most important regulatory mechanism by which right-to-left shunts decrease during one-lung ventilation (OLV), but the effects of pulmonary microarterial thrombosis and.
HCPLive
SEPTEMBER 9, 2024
Patients with positive endoscopic findings for upper gastrointestinal mucosal damage had a greater risk of developing Parkinson disease compared to those without mucosal damage.
CTVS
SEPTEMBER 9, 2024
CTVS is thrilled to welcome cardiothoracic surgeon Dr. Courtney Weber to our team. She is the second female surgeon to join CTVS, and one of only two female cardiothoracic surgeons in Central Texas. Dr. Weber completed her cardiothoracic surgery fellowship at the University of California in San Diego (UCSD) and will be part of our experienced team that surgically manages heart failure.
HCPLive
SEPTEMBER 9, 2024
Wells discussed the importance and recommended frequency for several factors, including lipid panels, chest X-rays, pregnancy tests, and flu vaccines.
American College of Cardiology
SEPTEMBER 9, 2024
In this episode, Andrea Price, MS, AACC hosts Hussein Abu Daya MD, FACC, Brian Rose, PA-C, MPH, AACC and Bailey Estes MSN, AGNP-C, to begin the PAD series with an introductory overview.
HCPLive
SEPTEMBER 9, 2024
Focusing on the complex pathophysiology of atopic dermatitis, Lindsay S. Ackerman, MD, FAAD, discusses the importance of looking beyond type 2 inflammation while treating patients.
American College of Cardiology
SEPTEMBER 9, 2024
What is the effect of early routine active percutaneous mechanical circulatory support (MCS) versus control treatment on 6-month all-cause mortality in patients with acute myocardial infarction-related cardiogenic shock (AMICS)?
HCPLive
SEPTEMBER 9, 2024
Medical experts review the FDA-approved oral JAK inhibitors for atopic dermatitis (abrocitinib, upadacitinib), highlighting differences from conventional therapies, their appeal, and the criteria for recommending them based on disease severity and patient characteristics.
American College of Cardiology
SEPTEMBER 9, 2024
What is the impact of concomitant vascular disease on the benefits and risks of anticoagulation for patients with device-detected atrial fibrillation (DDAF)?
HCPLive
SEPTEMBER 9, 2024
An investigation into basic and instrumental activities of daily living in older female patients found greater reliance in those with anemia.
HeartRhythm
SEPTEMBER 9, 2024
Pulsed field ablation (PFA) for the treatment of paroxysmal atrial fibrillation (AF) was validated to be safe and effective.1 Two PFA systems have been recently approved to treat paroxysmal AF in the United States (U.S.). Widespread adoption of this potentially transformative technology has brought into the focus the economics of AF with new therapies requiring significant capital and disposable investment.
HCPLive
SEPTEMBER 9, 2024
These data on depemokimab, a long-acting asthma treatment, suggest the medication reduces serious attacks by more than half and strongly reduces asthma exacerbations.
HeartRhythm
SEPTEMBER 9, 2024
In November 2022, de-identified data from S-ICD devices in the LATITUDE monitoring system were analyzed. The research reported in this paper adhered to the Declaration of Helsinki (2013) and the Common Rule (45 CFR 46), ensuring that ethical standards were upheld despite the research involving de-identified data from human subjects. Data from devices with <3 months implant duration (time since S-ICD implantation) were excluded, as well as data from clinics opting out of LATITUDE data analysis.
HCPLive
SEPTEMBER 9, 2024
Patients with high RF concentration treated with CZP were more likely to achieve DAS28-CRP low disease activity at week 104 than those treated with adalimumab.
American College of Cardiology
SEPTEMBER 9, 2024
Does semaglutide reduce risk for adverse cardiovascular (CV) events in patients with heart failure with preserved ejection fraction (HFpEF)?
HCPLive
SEPTEMBER 9, 2024
These data may help to inform and guide clinicians as well as policymakers in their allocation of efficient chronic urticaria management resources.
HeartRhythm
SEPTEMBER 9, 2024
Targeting the maximal ventricular resynchronization, with the shortest QRS duration (QRSd), is commonly implemented after cardiac resynchronization therapy (CRT).
HCPLive
SEPTEMBER 9, 2024
A panel of dermatologists discuss the evolution of JAK inhibitors for atopic dermatitis and how they fit into current treatment paradigms.
Expert insights. Personalized for you.
108 
Let's personalize your content